Sigawi Tal, Hamtzany Omer, Hurvitz Noa, Ishay Yuval, Dayan Roy, Arkadir David, Ilan Yaron
Department of Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University, Jerusalem 9112001, Israel.
Department of Neurology, Hadassah Medical Center, Faculty of Medicine, Hebrew University, Jerusalem 9112001, Israel.
Clin Pract. 2024 Jul 11;14(4):1375-1382. doi: 10.3390/clinpract14040110.
Neurological manifestations are common in patients with chronic liver diseases. This study aimed to depict the association between liver cirrhosis and Parkinson's disease (PD) and propose a clinically relevant diagnostic scheme. : We examined patients' medical records with PD and chronic liver impairment secondary to cirrhosis or liver metastases for temporal correlations between liver insult and Parkinsonian signs. Thirty-five individuals with PD and chronic liver impairment were included due to either cirrhosis or liver metastases. In all 22 patients with PD and liver metastases, the diagnosis of PD preceded the diagnosis of cancer. Conversely, patients with cirrhosis were often diagnosed with liver impairment before diagnosing PD. Age at diagnosis did not account for this difference. This study reinforces the potential clinical association between cirrhosis and PD. We also provide a diagnostic scheme that may guide therapeutic interventions and prognostic assessments.
神经学表现在慢性肝病患者中很常见。本研究旨在描述肝硬化与帕金森病(PD)之间的关联,并提出一种具有临床相关性的诊断方案。我们检查了患有PD以及由肝硬化或肝转移继发的慢性肝损伤患者的病历,以探究肝损伤与帕金森氏体征之间的时间相关性。35名因肝硬化或肝转移而患有PD和慢性肝损伤的个体被纳入研究。在所有22名患有PD和肝转移的患者中,PD的诊断先于癌症的诊断。相反,肝硬化患者在诊断出PD之前通常已被诊断出肝损伤。诊断时的年龄并不能解释这种差异。本研究强化了肝硬化与PD之间潜在的临床关联。我们还提供了一种诊断方案,该方案可能指导治疗干预和预后评估。